Wu Xiong
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Ferulic acid liposomes improve diabetic EPC angiogenesis by upregulating the AMPK/KLF4/FAM3A pathway.
Journal: In vitro cellular & developmental biology. Animal
Published: March 23, 2026
Liposome-iRGD loaded with astragaloside IV alleviates the functional damage of endothelial progenitor cells via the Hippo-YAP/TAZ signaling pathway.
Journal: In vitro cellular & developmental biology. Animal
Published: December 30, 2025
Astragaloside IV Relieves Mitochondrial Oxidative Stress Damage and Dysfunction in Diabetic Mice Endothelial Progenitor Cells by Regulating the GSK-3β/Nrf2 Axis.
Journal: Applied biochemistry and biotechnology
Published: March 13, 2025
PF-PEG@ASIV-EXO Hydrogel Accelerates Diabetic Wound Healing by Ferroptosis Resistance and Promoting Angiogenesis.
Journal: ACS biomaterials science & engineering
Published: September 23, 2024
Astragaloside promotes the secretion of MSC-derived exosomal miR-146a-5p by regulating TRAF6/NF-κB pathway to attenuate inflammation in high glucose-impaired endothelial cells.
Journal: In vitro cellular & developmental biology. Animal
Published: May 29, 2024
Discovery of β-sitosterol's effects on molecular changes in rat diabetic wounds and its impact on angiogenesis and macrophages.
Journal: International immunopharmacology
Published: August 30, 2023
Exosomes Derived from Astragaloside IV-pretreated Endothelial Progenitor Cells (AS-IV-Exos) Alleviated Endothelial Oxidative Stress and Dysfunction via the miR-210/ Nox2/ROS Pathway.
Journal: Current molecular medicine
Published: June 06, 2023
Endothelial Progenitor-Cell-Derived Exosomes Induced by Astragaloside IV Accelerate Type I Diabetic-wound Healing via the PI3K/AKT/mTOR Pathway in Rats.
Journal: Frontiers in bioscience (Landmark edition)
Published: May 23, 2023
Astragaloside IV promotes exosome secretion of endothelial progenitor cells to regulate PI3KR2/SPRED1 signaling and inhibit pyroptosis of diabetic endothelial cells.
Journal: Cytotherapy
Published: April 20, 2023
Astragaloside IV (ASIV) Mediates Endothelial Progenitor Cell (EPC) Exosomal LINC01963 to Inhibit Pyroptosis and Oxidative Stress in High Glucose-impaired Endothelial Cells.
Journal: Current molecular medicine
Published: May 25, 2022
Astragaloside IV - mediated endothelial progenitor cell exosomes promote autophagy and inhibit apoptosis in hyperglycemic damaged endothelial cells via miR-21/PTEN axis.
Journal: Folia histochemica et cytobiologica
Published: April 29, 2022
Astragaloside IV drug-loaded exosomes (AS-IV EXOs) derived from endothelial progenitor cells improve the viability and tube formation in high-glucose impaired human endothelial cells by promoting miR-214 expression.
Journal: Endokrynologia Polska
Published: December 15, 2021
Last Updated: 09/26/2026